2. Search Result
Search Result
Results for "

5-Aminosalicylic Acid

" in MedChemExpress (MCE) Product Catalog:

22

Inhibitors & Agonists

3

Peptides

2

Natural
Products

10

Isotope-Labeled Compounds

Cat. No. 상품명 Target 연구분야 Chemical Structure
  • HY-15027
    5-Aminosalicylic Acid
    30+ Cited Publications

    Mesalamine; 5-ASA; Mesalazine

    		 PPAR PAK NF-κB Endogenous Metabolite Inflammation/Immunology Cancer
    5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
    5-Aminosalicylic Acid
  • HY-66008
    N-Acetyl mesalazine

    N-Acetyl-5-Aminosalicylic Acid; N-Acetyl-ASA

    		 Drug Metabolite Inflammation/Immunology Cancer
    N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the primary intestinal metabolite of 5-Aminosalicylic Acid (HY-15027) and serves as a biomarker for evaluating the efficacy of 5-Aminosalicylic Acid (HY-15027). N-Acetyl mesalazine can scavenge free radicals, reduce DNA base hydroxylation, and ameliorate mucosal inflammation. N-Acetyl mesalazine can be used in the study of diseases such as colitis and colon cancer .
    N-Acetyl mesalazine
  • HY-W206016
    3-Aminosalicylic acid

    3-ASA

    		 Drug Intermediate Others
    3-Aminosalicylic acid (3-ASA) is a hydroxybenzoic acid compound. 3-Aminosalicylic acid serves as a building block for organic synthesis. It also acts as a potential impurity of 5-Aminosalicylic Acid (HY-15027) .
    3-Aminosalicylic acid
  • HY-15027S1
    5-Aminosalicylic acid-d3

    Mesalamine-d3; 5-ASA-d3; Mesalazine-d3

    		 Isotope-Labeled Compounds Endogenous Metabolite NF-κB PAK PPAR Inflammation/Immunology Cancer
    5-Aminosalicylic acid-d3 is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .
    5-Aminosalicylic acid-d3
  • HY-15027R
    5-Aminosalicylic Acid (Standard)

    Mesalamine (Standard); 5-ASA (Standard); Mesalazine (Standard)

    		 Reference Standards PPAR PAK NF-κB Endogenous Metabolite Inflammation/Immunology Cancer
    5-Aminosalicylic Acid (Standard) is the analytical standard of 5-Aminosalicylic Acid. This product is intended for research and analytical applications. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
    5-Aminosalicylic Acid (Standard)
  • HY-143704S
    5-Aminosalicylic acid-13C6 hydrochloride

    Mesalamine-13C6 hydrochloride; 5-ASA-13C6 hydrochloride; Mesalazine-13C6 hydrochloride

    		 PPAR NF-κB PAK Metabolic Disease
    5-Aminosalicylic acid-13C6 hydrochloride?(Mesalamine-13C6 hydrochloride; 5-ASA-13C6 hydrochloride; Mesalazine-13C6 hydrochloride) is the 13C labeled 5-Aminosalicylic Acidhydrochloride. 5-Aminosalicylic acid-13C6 hydrochloride?acts as a PPARγ agonist, and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .
    5-Aminosalicylic acid-13C6 hydrochloride
  • HY-15027S
    5-Aminosalicylic Acid-d3 hydrochloride

    Mesalamine-D3 hydrochloride; 5-ASA-D3 hydrochloride; Mesalazine-D3 hydrochloride

    		 Isotope-Labeled Compounds PPAR PAK NF-κB Endogenous Metabolite Inflammation/Immunology Cancer
    5-Aminosalicylic Acid-d3 (hydrochloride) is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) hydrochloride acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.
    5-Aminosalicylic Acid-d3 hydrochloride
  • HY-P10341
    ZP3022

    		GCGR Metabolic Disease
    ZP3022 is a dual agonist of glucagon-like peptide-1 (GLP-1) and gastrin that has the ability to sustainably improve glycemic control. Additionally, ZP3022 can effectively increase β-cell mass, promote β-cell proliferation, and enhance the function of pancreatic islets. ZP3022 can be used in anti-diabetic research .
    ZP3022
  • HY-15027S4
    5-Aminosalicylic acid-d7

    5-ASA-d7; Mesalamie-d7; Mesalazie-d7

    		 Isotope-Labeled Compounds PPAR PAK Endogenous Metabolite NF-κB Inflammation/Immunology Cancer
    5-Aminosalicylic acid-d7 (5-ASA-d7; Mesalamie-d7; Mesalazie-d7) is deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN) .
    5-Aminosalicylic acid-d7
  • HY-131265
    Mesalamine impurity P

    		PPAR PAK NF-κB Inflammation/Immunology Cancer
    Mesalamine impurity P is an impurity of Mesalamine (HY-15027). 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .
    Mesalamine impurity P
  • HY-15027S3
    5-Aminosalicylic acid-d3 disodium

    Mesalamine-d3 disodium; 5-ASA-d3 disodium; Mesalazine-d3 disodium

    		 PPAR NF-κB Endogenous Metabolite PAK Isotope-Labeled Compounds Inflammation/Immunology
    5-Aminosalicylic acid-d3 disodium is deuterated labeled 5-Aminosalicylic Acid (HY-15027). 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
    5-Aminosalicylic acid-d3 disodium
  • HY-15027S2
    5-Aminosalicylic acid-13C6

    Mesalamine-13C6; 5-ASA-13C6; Mesalazine-13C6

    		 PPAR PAK NF-κB Endogenous Metabolite Inflammation/Immunology
    5-Aminosalicylic acid- 13C6 is the 13C labeled 5-Aminosalicylic Acid . 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .
    5-Aminosalicylic acid-13C6
  • HY-W094747A
    Benzalazine

    		Drug Intermediate Inflammation/Immunology
    Benzalazine is a 5-azo derivative of 5-Aminosalicylic Acid (HY-15027) that can be used for the research of ulcerative colitis and Crohn's disease of the large intestine. The benzalazine metabolite 5-ASA and the 5-ASA metabolite acetyl-5-aminosalicylic acid are excreted mainly with the faeces .
    Benzalazine
  • HY-108127
    NAA-004

    NM-004; APAZA

    		 Glutathione Peroxidase Inflammation/Immunology
    NAA-004 (NM-004) is a novel azo compound formed by linking 5-aminosalicylic acid and 4-aminophenylacetic acid through an azo bond. NAA-004 has oral activity. NAA-004 can inhibit colon damage, intracavitary fluid accumulation, and MPO activity. NAA-004 can be used for research on colitis .
    NAA-004
  • HY-66008R
    N-Acetyl mesalazine (Standard)

    N-Acetyl-5-Aminosalicylic Acid (Standard); N-Acetyl-ASA (Standard)

    		 Drug Metabolite Reference Standards Inflammation/Immunology Cancer
    N-Acetyl mesalazine (Standard) (N-Acetyl-5-aminosalicylic acid (Standard)) is the analytical standard of N-Acetyl mesalazine (HY-66008). This product is intended for research and analytical applications. N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the primary intestinal metabolite of 5-Aminosalicylic Acid (HY-15027) and serves as a biomarker for evaluating the efficacy of 5-Aminosalicylic Acid (HY-15027). N-Acetyl mesalazine can scavenge free radicals, reduce DNA base hydroxylation, and ameliorate mucosal inflammation. N-Acetyl mesalazine can be used in the study of diseases such as colitis and colon cancer .
    N-Acetyl mesalazine (Standard)
  • HY-66008S
    N-Acetyl mesalazine-d3

    N-Acetyl-5-Aminosalicylic Acid-d3; N-Acetyl-ASA-d3

    		 Isotope-Labeled Compounds Drug Metabolite Inflammation/Immunology Cancer
    N-Acetyl mesalazine-d3 (N-Acetyl-5-aminosalicylic acid-d3) is the deuterium labeled N-Acetyl mesalazine (HY-66008). N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the primary intestinal metabolite of 5-Aminosalicylic Acid (HY-15027) and serves as a biomarker for evaluating the efficacy of 5-Aminosalicylic Acid (HY-15027). N-Acetyl mesalazine can scavenge free radicals, reduce DNA base hydroxylation, and ameliorate mucosal inflammation. N-Acetyl mesalazine can be used in the study of diseases such as colitis and colon cancer .
    N-Acetyl mesalazine-d3
  • HY-66008S1
    N-Acetyl mesalazine-d3-1

    N-Acetyl-5-Aminosalicylic Acid-d3-1; N-Acetyl-ASA-d3-1

    		 Isotope-Labeled Compounds Drug Metabolite Inflammation/Immunology Cancer
    N-Acetyl mesalazine-d3-1 (N-Acetyl-5-aminosalicylic acid-d3-1) is deuterium labeled N-Acetyl mesalazine (HY-66008). N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the primary intestinal metabolite of 5-Aminosalicylic Acid (HY-15027) and serves as a biomarker for evaluating the efficacy of 5-Aminosalicylic Acid (HY-15027). N-Acetyl mesalazine can scavenge free radicals, reduce DNA base hydroxylation, and ameliorate mucosal inflammation. N-Acetyl mesalazine can be used in the study of diseases such as colitis and colon cancer .
    N-Acetyl mesalazine-d3-1
  • HY-66008S2
    N-Acetyl mesalazine-13C6

    N-Acetyl-5-Aminosalicylic Acid-13C6; N-Acetyl-ASA-13C6

    		 Isotope-Labeled Compounds Drug Metabolite Inflammation/Immunology Cancer
    N-Acetyl mesalazine- 13C6 (N-Acetyl-5-aminosalicylic acid- 13C6) is a deuterated labeled N-Acetyl mesalazine (HY-66008). N-Acetyl mesalazine (N-Acetyl-5-aminosalicylic acid) is the primary intestinal metabolite of 5-Aminosalicylic Acid (HY-15027) and serves as a biomarker for evaluating the efficacy of 5-Aminosalicylic Acid (HY-15027). N-Acetyl mesalazine can scavenge free radicals, reduce DNA base hydroxylation, and ameliorate mucosal inflammation. N-Acetyl mesalazine can be used in the study of diseases such as colitis and colon cancer .
    N-Acetyl mesalazine-13C6
  • HY-101744
    Ipsalazide

    		Autophagy Inflammation/Immunology
    Ipsalazide is a novel sulfasalazine analog designed to release 5-aminosalicylic acid and a nontoxic carrier molecule in the gastrointestinal tract.
    Ipsalazide
  • HY-P11243
    EphA4 agonist compound 23

    		Ephrin Receptor Neurological Disease
    EphA4 agonist compound 23 is a novel EphA4 agonist peptide mimic. EphA4 agonist compound 23 exhibits high affinity, high selectivity, and significant receptor activation ability. EphA4 agonist compound 23 is commonly used in the study of neurodegenerative diseases .
    EphA4 agonist compound 23
  • HY-W206016S
    3-Aminosalicylic acid-d3

    3-ASA-d3

    		 Isotope-Labeled Compounds Others
    3-Aminosalicylic acid-d3 is deuterium labeled 3-Aminosalicylic acid. 3-Aminosalicylic acid (3-ASA) is a hydroxybenzoic acid compound. 3-Aminosalicylic acid serves as a building block for organic synthesis. It also acts as a potential impurity of 5-Aminosalicylic Acid (HY-15027) .
    3-Aminosalicylic acid-d3
  • HY-P10876
    mcK6A1

    		Amyloid-β Neurological Disease
    mcK6A1 is an inhibitor for the aggregation of amyloid-β (Aβ), that selectively binds to the 16KLVFFA21 segment of Aβ42, forms an extended β-folded structure, and inhibits the formation of Aβ42 oligomers. mcK6A1 can be used in research of Alzheimer's disease and other amyloid-related diseases .
    mcK6A1

온라인 문의

Your information is safe with us. * Required Fields.

호칭

  

Country or Region *

고객명 *

 

회사명 *

Department *

     

메일주소 *

 

상품명 *

Cat. No.

  

Requested quantity *

전화번호 *

     

비고

온라인 문의

Inquiry Information

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent: